Bausch Health — Bausch & Lomb
Tracked across 6 events · 37 articles · First seen Jun 18, 2026 · Last active Sep 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bausch + Lomb Corporation announced new findings from its third annual State of Dry Eye survey, highlighting the emotional impact of dry eye and the benefits of prescription treatments, which could positively influence its product sales and market position.
Jul 01, 2026 · 6 articles
Tech
Impact: Bausch Health — Bausch & Lomb is the creator and owner of the Orphia platform, which expands its offerings beyond traditional products into digital health, potentially improving its market position.
Jul 09, 2026 · 6 articles
Regulatory
Bausch Health — Bausch & Lomb Corporation announced that the European Union granted CE Mark approval for SeeLyra, its next-generation femtosecond laser platform. SeeLyra is designed to provide surgeons with enhanced precision and control in…
Impact: Bausch Health — Bausch & Lomb received CE Mark approval for its next-generation SeeLyra femtosecond laser, expanding its European surgical device portfolio. The approval is a positive but incremental development for the company's premium cataract and refractive surgery business.
Sep 11, 2026 · 6 articles
Regulatory
Impact: Bausch Health — Bausch & Lomb is the licensee for NicOx's first product VYZULTA, but is not directly involved in the NCX 470 NDA submission.
Aug 10, 2026 · 6 articles
Business
Impact: Bausch Health — Bausch & Lomb holds exclusive worldwide license for VYZULTA, a commercial product generating revenue for NicOx. This provides ongoing cash flow but is not the focus of the announcement.
Sep 02, 2026 · 6 articles
Business
Impact: Bausch + Lomb is the exclusive worldwide licensee for NicOx's first product, VYZULTA.
Jun 18, 2026 · 7 articles
90
European Union granted CE Mark approval Bausch Health — Bausch & LombBausch + Lomb SeeLyra CE...
85
Bausch Health — Bausch & Lomb announced CE Mark approvalBausch + Lomb SeeLyra CE...
50
Bausch Health — Bausch & Lomb seeking regulatory approvals United StatesBausch + Lomb SeeLyra CE...
ERGEN INTELLIGENCE
Track Bausch Health — Bausch & Lomb live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard